Correlation Between NervGen Pharma and Defence Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NervGen Pharma and Defence Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NervGen Pharma and Defence Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NervGen Pharma Corp and Defence Therapeutics, you can compare the effects of market volatilities on NervGen Pharma and Defence Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NervGen Pharma with a short position of Defence Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NervGen Pharma and Defence Therapeutics.

Diversification Opportunities for NervGen Pharma and Defence Therapeutics

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between NervGen and Defence is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding NervGen Pharma Corp and Defence Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Defence Therapeutics and NervGen Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NervGen Pharma Corp are associated (or correlated) with Defence Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Defence Therapeutics has no effect on the direction of NervGen Pharma i.e., NervGen Pharma and Defence Therapeutics go up and down completely randomly.

Pair Corralation between NervGen Pharma and Defence Therapeutics

Assuming the 90 days horizon NervGen Pharma Corp is expected to generate 8.17 times more return on investment than Defence Therapeutics. However, NervGen Pharma is 8.17 times more volatile than Defence Therapeutics. It trades about 0.19 of its potential returns per unit of risk. Defence Therapeutics is currently generating about 0.22 per unit of risk. If you would invest  159.00  in NervGen Pharma Corp on September 18, 2024 and sell it today you would earn a total of  27.00  from holding NervGen Pharma Corp or generate 16.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

NervGen Pharma Corp  vs.  Defence Therapeutics

 Performance 
       Timeline  
NervGen Pharma Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in NervGen Pharma Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, NervGen Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Defence Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Defence Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, Defence Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

NervGen Pharma and Defence Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NervGen Pharma and Defence Therapeutics

The main advantage of trading using opposite NervGen Pharma and Defence Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NervGen Pharma position performs unexpectedly, Defence Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Defence Therapeutics will offset losses from the drop in Defence Therapeutics' long position.
The idea behind NervGen Pharma Corp and Defence Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Stocks Directory
Find actively traded stocks across global markets